About Thioredoxin Systems
Thioredoxin Systems is a company based in Solna (Sweden) founded in 1994 by Arne Holmgren.. Thioredoxin Systems has raised $2.4 million across 1 funding round from investors including GU Ventures and Gobia. Thioredoxin Systems offers products and services including EbsArgent. Thioredoxin Systems operates in a competitive market with competitors including Insmed, Affinivax, Eligo Bioscience, Aridis Pharma and Basilea, among others.
- Headquarter Solna, Sweden
- Founders Arne Holmgren
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Thioredoxin Systems Ab
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.4 M (USD)
in 1 rounds
-
Latest Funding Round
$2.4 M (USD), Unspecified
Oct 30, 2024
-
Investors
GU Ventures
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Thioredoxin Systems
Thioredoxin Systems offers a comprehensive portfolio of products and services, including EbsArgent. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Targets bacterial redox systems to combat resistant urinary tract infections.
Funding Insights of Thioredoxin Systems
Thioredoxin Systems has successfully raised a total of $2.4M through 1 strategic funding round. The most recent funding activity was a Unspecified round of $2.4 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Unspecified — $2.4M
-
First Round
First Round
(30 Oct 2024)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2024 | Amount | Unspecified - Thioredoxin Systems | Valuation | GU Ventures , Gobia |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Thioredoxin Systems
Thioredoxin Systems has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include GU Ventures and Gobia. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in tech startups
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Thioredoxin Systems
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Thioredoxin Systems
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Thioredoxin Systems Comparisons
Competitors of Thioredoxin Systems
Thioredoxin Systems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insmed, Affinivax, Eligo Bioscience, Aridis Pharma and Basilea, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of small molecule inhibitors for rare lung diseases
|
|
| domain | founded_year | HQ Location |
Technology-based conjugate vaccines against infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
In vivo gene editing technology is developed for microbiome modulation.
|
|
| domain | founded_year | HQ Location |
Provider of human monoclonal antibodies against infectious diseases
|
|
| domain | founded_year | HQ Location |
Antibiotics, antifungals, and oncology drugs are developed for disease treatment.
|
|
| domain | founded_year | HQ Location |
Microbiome therapies are developed for treating intestinal dysbiosis diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Thioredoxin Systems
When was Thioredoxin Systems founded?
Thioredoxin Systems was founded in 1994 and raised its 1st funding round 30 years after it was founded.
Where is Thioredoxin Systems located?
Thioredoxin Systems is headquartered in Solna, Sweden.
Who is the current CEO of Thioredoxin Systems?
Mohamad Takwa is the current CEO of Thioredoxin Systems.
Is Thioredoxin Systems a funded company?
Thioredoxin Systems is a funded company, having raised a total of $2.4M across 1 funding round to date. The company's 1st funding round was a Unspecified of $2.4M, raised on Oct 30, 2024.
What does Thioredoxin Systems do?
Thioredoxin Systems was founded in 1994 in Solna, Sweden, within the biotechnology sector. Focus is placed on developing antibiotics to combat pathogenic bacteria. Operations center on the creation of EbsArgent, a synthetic organoselenium drug that integrates ebselen with silver for antimicrobial effects. Silver is routinely applied as a coating on medical devices and wound dressings to prevent infections. Leadership includes founder Arne Holmgren and CEO Mohamad Takwa.
Who are the top competitors of Thioredoxin Systems?
Thioredoxin Systems's top competitors include Aridis Pharma, Insmed and MaaT Pharma.
What products or services does Thioredoxin Systems offer?
Thioredoxin Systems offers EbsArgent.
Who are Thioredoxin Systems's investors?
Thioredoxin Systems has 2 investors. Key investors include GU Ventures, and Gobia.